Benzinga | May 13, 2021 08:05AM EDT

Dare Bioscience Q1 EPS $(0.16) Beats $(0.22) Estimate

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. This is a 11.11 percent increase over losses of $(0.18) per share from the same period last year.